Gnrh ovulation trigger dose and oocyte maturation

Does GnRh ovulation trigger dose make a difference in oocyte maturation and disintegration in PCOS patients undergoing controlled ovarian hyperstimulation?

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014102019608N1

Enrollment

200

Registered

2014-11-22

Start date

2014-12-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS. Ovay ( noninflammatory), PCOS

Interventions

Intervention 1: Decapeptyl 0.2mg as standard practice. Intervention 2: intervention group 0.3mg decapeptyl.

Treatment - Drugs

Decapeptyl 0.2mg as standard practice

intervention group 0.3mg decapeptyl

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: PCO patients undergoing fresh IVF/ICSI cycle in antagonist protocol between age of 20-50, BMI 19-30

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Rates of oocyte maturation and rate of oocyte disintegrationin both groups. Timepoint: egg collection day. Method of measurement: percentage of oocyte maturation & percentage of disintegration.	—

Secondary

Measure	Time frame
Rate of OHSS (early& late ), cacellation rate, pregnancy rate, clinical/ongoing pregnancy rate,multiple pregnancy rates and early pregnancy losses. Timepoint: first trimester. Method of measurement: percentage of : OHSS, pregnancy rate,multiple pregnancy rate and early pregnancy losses.	—

Countries

United Arab Emirates

Contacts

Public ContactDr Amal AL Mulla

Dubai Health Authority

aaalmulla73@yahoo.com0087144393804

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026